Category: 3. Business

  • China factory activity edges up in November but remains in contraction

    China factory activity edges up in November but remains in contraction

    A worker walks past molten steel at a steel factory in Huai’an, in China’s eastern Jiangsu province on July 22, 2025.

    – | Afp | Getty Images

    China’s factory activity edged higher in November but remained stuck in contraction for the eighth consecutive month, while services weakened as the boost from earlier holidays faded, according to official data released Sunday.

    The manufacturing purchasing managers’ index rose to 49.2, up 0.2 points from October, the National Bureau of Statistics said. The figures were in line with economists’ expectations in a Reuters poll, but remained below the 50-point mark that separates expansion from contraction.

    The non-manufacturing business activity index fell to 49.5, down 0.6 points from October, while the composite PMI output index eased to 49.7, indicating a slight pullback in both manufacturing and services activities.

    Supply and demand in manufacturing improved modestly, said Huo Lihui, chief statistician at the bureau’s Service Industry Survey Center, with the production index reaching the 50 threshold and new orders rising to 49.2.

    High-tech manufacturing stayed in expansion for a tenth straight month at 50.1, even as equipment manufacturing and consumer goods producers slipped below 50. Energy-intensive industries posted a mild rebound to 48.4, up 1.1 percentage points from October.

    Smaller factories recorded the strongest improvement. The PMI for small enterprises jumped to 49.1, its highest in nearly six months, while medium-sized firms edged up to 48.9. Large manufacturers weakened, falling to 49.3.

    Market confidence showed a slight uptick. The index measuring expectations for production and operations rose to 53.1. Industries including non-ferrous metal smelting and aerospace-related equipment reported particularly strong sentiment, with readings above 57.

    Holiday boost fades

    Non-manufacturing activity, covering construction and services, softened, weighed down by services. Huo attributed the decline partly to the fading impact of earlier holiday-driven spending.

    China’s Golden Week holiday, which typically lifts travel and consumer spending before activity normalizes in the following months, ran from Oct. 1 to 8 this year.

    Service-sector activity fell to 49.5, down 0.6 percentage points from October, though pockets of strength remained: railway transportation, telecommunications, broadcasting and satellite transmission, and financial services all posted readings above 55.

    Real estate and residential services continued to lag below the 50 mark, underscoring persistent weakness in property-related activity. Construction activity improved to 49.6, aided by stronger expectations for near-term growth, with that sector’s sentiment index climbing to 57.9.

    The non-manufacturing new orders index slipped to 45.7, reflecting softer demand. Input prices rose to 50.4, and service-sector sales prices, while still below 50, narrowed their decline.

    Manufacturing employment ticked up slightly to 48.4, while non-manufacturing employment rose marginally to 45.3. Supplier delivery times for factories improved to 50.1.

    China surveys roughly 3,200 manufacturers and 4,300 non-manufacturing firms for the monthly PMI readings, which are seasonally adjusted and considered a leading indicator for economic momentum.

    Trade strains

    China’s manufacturing activity has contracted since April, when U.S. President Donald Trump launched new tariffs that squeezed producers.

    Industrial profits fell 5.5% in October, the sharpest drop since June, reversing the strong gains seen in late summer. Earnings for the first ten months at major industrial firms rose 1.9%, slowing from the January–September pace.

    The broader Chinese economy has cooled as growth slipped to 4.8% in the third quarter.

    Trade tensions with the U.S. spiked in October as Washington threatened new 100% tariffs before both sides reached a late-month deal in South Korea. The agreement cut U.S. fentanyl-linked tariffs to 10% from 20%, paused Beijing’s rare-earth controls for a year and reopened China’s purchases of American soybeans and other farm goods.

    Despite the truce, demand at home remains soft. A drawn-out property slump and weak labor conditions are weighing on consumer spending. Policymakers have signaled a longer-term push to lift consumption and tech self-reliance but have avoided major new stimulus as the economy remains on track to meet its 5% growth target.

    Continue Reading

  • Harper Adams University gets £500,000 for AI and engineering

    Harper Adams University gets £500,000 for AI and engineering

    A university has received £500,000 to improve teaching of artificial intelligence and engineering.

    Harper Adams University, said £400,000 would be spent on developing a new centre in Telford for artificial intelligence in manufacturing, agricultural technology and engineering.

    The rest would be spent at its Edgmond campus to develop its simulation laboratory, where it tested products before they are produced.

    Harper Adams is one of 60 universities or colleges to receive funding from the Office for Students, England’s higher education regulator.

    University Vice-Chancellor Professor Ken Sloan, said: “This funding will help us to deliver high-quality AI learning in the heart of the community we serve.”

    The university’s base in Telford town centre, in a building known as the Quad, will house “high-specification IT equipment, including AI workstations, immersive learning pods, edge computing servers, and VR/AR devices” it said.

    Its Collaborative Simulation Laboratory at its main campus was “already at the heart of engineering teaching and research”, it said, and used “advanced simulation techniques to test and refine products before physical versions are made”.

    Continue Reading

  • Rail users warned of longer journeys due to ‘vital’ Cornwall work

    Rail users warned of longer journeys due to ‘vital’ Cornwall work

    Rail passengers have been warned of longer journey times while travelling through Cornwall due to “vital” engineering work.

    Network Rail said the work would take place between Truro and Penzance from Monday, 1 December, until Friday, 5 December.

    It said buses would replace trains between Truro and Penzance, and rail tickets would be accepted on local buses between St Erth and St Ives.

    Mark Parker, Network Rail lead portfolio manager, said: “I’d like to thank passengers in advance for their patience as we carry out this vital work to make journeys better and more reliable in Cornwall.”

    Network Rail said new track, sleepers and ballast would be installed near Redruth, with track replaced near Camborne, and track equipment also upgraded near Penzance and St Erth.

    Lee Goodson, Great Western Railway station manager for west Cornwall, said: “During these dates no trains can stop at Redruth, Camborne, Hayle, St Erth or Penzance or at any of the stations on the St Ives Bay Line.

    “Trains will still be able to run at Truro for Falmouth Docks as well as trains for Exeter St Davids or London Paddington. But CrossCountry trains will not be operating between Truro and Plymouth.”

    Mr Goodson added: “It’s important that customers are aware these alternative travel arrangements will make journey times much longer.”

    Continue Reading

  • ‘I started a bakery over pain of kids’ intolerances’

    ‘I started a bakery over pain of kids’ intolerances’

    Eleanor LawsonWest Midlands

    Borough 22 Doughnuts A man in a blue hoodie laughs as he stands in front of a grey wall with a blue stripe painted on it.Borough 22 Doughnuts

    Ryan Panchoo started Borough 22 Doughnuts after his own children struggled to find food that they enjoyed

    “My kids would be so excited to see their friends, but as soon as the food came out, it was just disappointment and segregation because they were so isolated.”

    Ryan Panchoo set out to develop his own allergy friendly products out of the “heartbreak” of his two children’s intolerances, despite having had no previous background in cookery or baking.

    More than a decade later and Mr Panchoo has scooped several awards for Borough 22 Doughnuts, his vegan, gluten-free and nut-free bakery, which is also Halal and Kosher-certified.

    Having previously only been based in London with a website shipping nationwide, Borough 22 Doughnuts now has a six-week pop-up in Birmingham’s Selfridges, with the possibility of staying in the city on the horizon.

    He set out on his endeavour after his own children, now aged 15 and 19, struggled when they were younger to find allergen-free food that was also tasty.

    Products containing either gluten or dairy caused them to react – the reaction to dairy being particularly violent.

    Mr Panchoo, 46, said it led to a “pain point as a parent”.

    “They can’t eat what their friends are eating, which looks amazing, and they can’t be part of that bigger picture,” he said.

    “The food they have is safe for them but it’s just boring, it’s bland, it’s kind of dry and it just really used to break my heart as a parent. I really felt for them, and that was the catalyst for kickstarting the company.”

    Borough 22 Doughnuts A stand of different coloured doughnuts with a blue sign saying 'Borough 22' in white writing on it.Borough 22 Doughnuts

    Borough 22 Doughnuts began as a “side project” in 2014

    Mr Panchoo, from Brockley in south London, had worked for a property investment company after starting out as a bricklayer, so baking was a whole new world.

    He started making and selling baked gluten and dairy free doughnuts in October 2014 as “a side project”, which became award-winning, but he still wanted to master the art of an allergen-friendly deep-fried doughnut.

    “After eight years of trial and error, I finally cracked it on 1 May 2022,” he said.

    “It’s just phenomenal how that changed the face of the business.”

    Having perfected his fried doughnuts, Mr Panchoo registered Borough 22 Doughnuts as an official company in February 2023.

    ‘Inclusive as possible’

    All of the doughnuts are dairy-free and gluten-free, with the company sourcing oats from the only certified gluten-free oat farm in the UK. They are also and made in a completely nut-free environment.

    Mr Panchoo said they were almost completely free of the UK’s main 14 allergens, excluding soya in some of the doughnuts’ toppings.

    “The aim for me is to make these doughnuts as inclusive as possible so that nobody has to feel like they’re isolated, like I experienced with my children,” he said.

    Since setting up in 2014, the “free from” sector has become huge business.

    According to the Grocer magazine it is worth £4.2bn to the UK economy annually, and in May the British Baker magazine said the sector was one of the fastest growing in the bakery industry.

    Borough 22 Doughnuts Three men stand in front of a blue food truck in Selfridges which says Borough 22 on it in white writing. Several doughnuts of different colours are on display.Borough 22 Doughnuts

    Borough 22 Doughnuts could ultimately set up a permanent base in Birmingham, Mr Panchoo said

    Mr Panchoo said Birmingham was a natural next step for the company, with large numbers of online orders coming to the city already, and having sold more than 3,000 doughnuts in two days at a festival in Digbeth this year.

    If the brand sells well in Selfridges, he said there was an opportunity for the firm to stay permanently in Birmingham.

    More than a decade on from first starting the business, Mr Panchoo said things had improved for people with allergies and intolerances in the UK, especially since the introduction of Natasha’s Law – named after Natasha Ednan-Laperouse, who died aged 15 after eating a baguette containing hidden sesame seeds.

    “Natasha’s Law forced people to wake up and recognise that these things are serious,” he said.

    But while awareness is growing, he believes for many companies, catering for allergies is done with a “tick box mentality”.

    “A lot of brands are jumping on it just because of the commercials, to make some money,” he said.

    “We really want to just make amazing food that just happens to be free from. We don’t want to be niche. There’s a lot of stigma around free-from food being sub-par and we want to change that.”

    Continue Reading

  • Roberts bakery bread quality dropped following fire

    Roberts bakery bread quality dropped following fire

    A bread firm that outsourced production to another bakery after a factory fire experienced “quality issues and further loss of sales”, according to financial documents.

    Roberts Bakery was saved from closure recently by a rescue deal – two years after a blaze at its Northwich headquarters in Cheshire.

    The fire, in 2023, resulted in production dropping to a third of previous output for more than a year.

    The 138-year-old firm had already suffered low sales after the 2020 coronavirus pandemic and was “further challenged” by sharp increases in wheat flour prices following the outbreak of the Russia-Ukraine war in 2022 and rising energy costs, according to Companies House documents.

    A significant fire damaged one of the bread plants in June 2023, leading to the firm having to rebuild its premises.

    “During the rebuild period, production was outsourced to another bakery which led to quality issues and further loss of sales as customers turned to competitors,” the documents say.

    “The company invested heavily in restoring the site but the prolonged disruption resulted in ongoing supply challenges and a damaged reputation for reliability.”

    In July, the family-run firm announced sales had “not rebounded as anticipated” following the fire – with turnover falling from £96m in 2023 to £76m in 2024.

    The company said at the time that it planned to cut up to 250 jobs from its 700-strong workforce.

    Three months later it was revealed the company had been saved after Boparan Private Office (BPO), owned by food processing entrepreneur Ranjit Boparan, backed a management team takeover.

    Continue Reading

  • Diagnostic and Critical Care Challenges in Rapidly Progressive Interstitial Lung Disease Secondary to Multiple Myeloma

    Diagnostic and Critical Care Challenges in Rapidly Progressive Interstitial Lung Disease Secondary to Multiple Myeloma

    Continue Reading

  • Early Functional and Radiological Outcomes of Radial Head Replacement in the Management of Radial Head Fractures: A Prospective Study

    Early Functional and Radiological Outcomes of Radial Head Replacement in the Management of Radial Head Fractures: A Prospective Study

    Continue Reading

  • A Look at Otis (OTIS) Valuation Following Gen3 Core Elevator Upgrades and Market Expansion

    A Look at Otis (OTIS) Valuation Following Gen3 Core Elevator Upgrades and Market Expansion

    Otis Worldwide (OTIS) has announced a significant upgrade to its Gen3 Core elevator lineup, now featuring larger door openings, increased load capacity, and smart digital enhancements. These additions are designed to better serve low-rise buildings across the U.S. and Canada.

    See our latest analysis for Otis Worldwide.

    These Gen3 Core enhancements arrive as Otis Worldwide’s share price has traded sideways recently, holding near $88.85. The company has achieved a long-term total shareholder return of 47% over five years, indicating steady value creation. While the year’s total return is down 12%, momentum is showing subtle signs of recovery with a modest 2.9% gain in the last three months. This suggests investors may be responding to product innovations and renewed growth prospects.

    If news of Otis’s upgraded technology has you curious about what else might be out there, it could be the perfect time to discover fast growing stocks with high insider ownership

    With these product upgrades and a modest recent rebound in share price, is Otis currently undervalued by the market and offering a compelling entry point, or is future growth already reflected in today’s price?

    Otis Worldwide’s most widely followed narrative sees the stock trading well below an updated fair value estimate, with share price lagging advanced growth projections. This fair value suggests analysts are seeing upside potential from today’s $88.85 closing price.

    The accelerating momentum in modernization orders, up 22% in the quarter and supported by a record-high backlog, positions Otis to benefit from the global trend of aging building infrastructure. This trend is expected to drive a multi-year growth cycle for modernization and associated high-margin service revenue, with a positive impact on both revenue and earnings.

    Read the complete narrative.

    Ready to see the big drivers behind Otis’s surge in fair value? Earnings projections, margin gains, and a play for future market share are at the core of this story. Analysts are betting on growth levers you might not expect. Discover how ambitious assumptions are shaping this price target.

    Result: Fair Value of $103.25 (UNDERVALUED)

    Have a read of the narrative in full and understand what’s behind the forecasts.

    However, persistent weakness in China or a downturn in commercial real estate demand could quickly erode Otis’s growth outlook and undermine current analyst optimism.

    Find out about the key risks to this Otis Worldwide narrative.

    While fair value estimates signal Otis shares are undervalued, a look at the price-to-earnings ratio offers a different angle. Otis trades at 25.7 times earnings, slightly above the Machinery industry’s average of 24.8 but noticeably below the peer average of 33.9. The fair ratio our models suggest is 26.7, indicating that today’s pricing leaves little room for error if industry sentiment shifts. Could valuation risks outweigh the upside if growth fails to accelerate?

    See what the numbers say about this price — find out in our valuation breakdown.

    NYSE:OTIS PE Ratio as at Nov 2025

    If you see the numbers differently or want to dig deeper into the data yourself, you can shape your own Otis Worldwide narrative in just a few minutes. Do it your way.

    A great starting point for your Otis Worldwide research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.

    Smart investing means staying ahead of the curve. Don’t miss your chance to uncover stocks redefining growth, value, and innovation using Simply Wall Street’s powerful tools.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

    Companies discussed in this article include OTIS.

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

    Continue Reading

  • Assessing Host Hotels & Resorts Value After Share Price Rises 9.6% on Travel Demand News

    Assessing Host Hotels & Resorts Value After Share Price Rises 9.6% on Travel Demand News

    • Ever wondered if Host Hotels & Resorts could be trading for less than it’s truly worth? You’re not alone, and today’s market gives us plenty of reasons to dig into the numbers.

    • After climbing 9.6% over the past month and returning 33.7% in five years, the stock has shown there is both growth potential and fresh investor interest bubbling beneath the surface.

    • New developments in the hospitality sector, such as increased travel demand and strategic acquisitions by competitors, have added some optimism and volatility to hotel REITs. Recent headlines point to shifting trends in business and leisure travel, which have also contributed to the latest movement in Host’s share price.

    • On our six-point valuation check, Host Hotels & Resorts scores a 4 out of 6 for being undervalued, making it a compelling candidate for deeper analysis. We will break down how that score is calculated and, more importantly, explore an even smarter approach to understanding the company’s real worth by the end of the article.

    Host Hotels & Resorts delivered 1.2% returns over the last year. See how this stacks up to the rest of the Hotel and Resort REITs industry.

    The Discounted Cash Flow (DCF) model projects a company’s future cash flows and discounts them back to today’s value, providing an estimate of what the business is fundamentally worth. For Host Hotels & Resorts, this approach uses adjusted funds from operations to forecast future free cash flow and then applies a discount rate to translate those future dollars into today’s terms.

    Currently, Host Hotels & Resorts reports Free Cash Flow of $1.387 billion. While analysts provide reliable estimates for up to five years, Simpy Wall St extrapolates further, showing projected annual Free Cash Flows between $1.12 billion and nearly $1.2 billion over the next decade. The methodology accounts for both modest growth and periods of stability as typical in the hotel and resort REITs sector.

    Using this conservative projection framework, the resulting intrinsic value per share is $28.46. Compared to the current market price, this indicates the stock is trading at a 38.1% discount to its estimated value.

    Result: UNDERVALUED

    Our Discounted Cash Flow (DCF) analysis suggests Host Hotels & Resorts is undervalued by 38.1%. Track this in your watchlist or portfolio, or discover 914 more undervalued stocks based on cash flows.

    HST Discounted Cash Flow as at Nov 2025

    Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Host Hotels & Resorts.

    The Price-to-Earnings (PE) ratio is a widely used benchmark for valuing profitable companies like Host Hotels & Resorts. It measures how much investors are willing to pay for each dollar of earnings, making it a practical tool for comparing companies in the same industry or with similar growth profiles.

    Generally, companies with higher expected earnings growth or lower risk profiles tend to have higher PE ratios, while those with slower growth or higher perceived risk tend to have lower multiples. A “normal” or “fair” PE is shaped not just by profits but also by factors such as stability, sector trends, and investor sentiment.

    Host Hotels & Resorts currently trades at a PE ratio of 16.43x. This is just above the Hotel and Resort REITs industry average of 15.63x, but well below the peer average of 24.74x. This means the stock appears relatively modestly priced given both the industry context and what direct competitors trade at.

    Rather than relying only on peer or industry averages, Simply Wall St has developed the proprietary “Fair Ratio” metric, which in this case stands at 29.92x. The Fair Ratio sets a tailored benchmark based on Host Hotels & Resorts’ earnings growth, its profit margins, specific risk profile, and market cap. It is designed to account for more than surface-level comparisons, giving a richer view of fair value for the stock.

    Since Host Hotels & Resorts’ current PE ratio of 16.43x is well below its Fair Ratio of 29.92x, the stock appears undervalued by this measure and may have attractive upside potential for investors seeking value in the sector.

    Result: UNDERVALUED

    NasdaqGS:HST PE Ratio as at Nov 2025
    NasdaqGS:HST PE Ratio as at Nov 2025

    PE ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1437 companies where insiders are betting big on explosive growth.

    Earlier we mentioned that there is an even better way to understand valuation, so let’s introduce you to Narratives. A Narrative connects your story or perspective about a company, such as your forecasts for fair value, revenue growth, and profit margins, to a financial forecast and ultimately a fair value estimate. This allows you to visualize how different assumptions may play out over time.

    Narratives transform traditional stock research into a dynamic process where investors can align their view of a company’s future with real numbers. This makes it easy to see how changing your outlook or new events impact the valuation. Narratives are available within the Simply Wall St Community page and are used by millions of investors to compare Fair Value and current Price, supporting more confident investment decisions as information evolves.

    Because Narratives update automatically when new data or news comes in, your analysis stays timely without extra effort. For example, one investor might use an optimistic Narrative for Host Hotels & Resorts, citing improved revenue growth rates and a bullish price target of $22.00, while another could focus on market risks and assign a conservative $16.00 target. Narratives let you explore both stories, see the numbers behind them, and decide which aligns best with your own view.

    Do you think there’s more to the story for Host Hotels & Resorts? Head over to our Community to see what others are saying!

    NasdaqGS:HST Community Fair Values as at Nov 2025
    NasdaqGS:HST Community Fair Values as at Nov 2025

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

    Companies discussed in this article include HST.

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

    Continue Reading

  • Is Amneal Pharmaceuticals Still an Opportunity After 61% Price Surge in 2025?

    Is Amneal Pharmaceuticals Still an Opportunity After 61% Price Surge in 2025?

    • Wondering if Amneal Pharmaceuticals is a hidden value or a stock that’s already run its course? You’re not alone, and plenty of investors are taking a close look at the numbers right now.

    • After an incredible 61.3% gain year-to-date and a remarkable 415.2% return over three years, the share price has caught serious momentum. This suggests growing optimism or changing risk perceptions around the company.

    • Much of the recent buzz traces back to industry developments and regulatory updates that have placed Amneal in the spotlight, sparking both excitement and debate among market watchers. Wider trends in generic pharmaceuticals and recent product approvals have fueled speculation about the company’s next moves.

    • Based on our valuation framework, Amneal scores 5 out of 6 on our valuation checks, which puts it ahead of most of its peers. Here is a closer look at what those metrics really mean, along with a fresh perspective on finding real value that goes beyond the basics.

    Amneal Pharmaceuticals delivered 51.4% returns over the last year. See how this stacks up to the rest of the Pharmaceuticals industry.

    The Discounted Cash Flow (DCF) model estimates a company’s intrinsic value by projecting future cash flows and then discounting them back to their present value. This approach helps investors understand what the company is truly worth today based on expected future performance.

    For Amneal Pharmaceuticals, the DCF analysis uses a two-stage Free Cash Flow to Equity method. The latest reported Free Cash Flow is $245.66 Million, with analysts expecting robust growth ahead. By 2027, projections place annual Free Cash Flow at $500 Million. Extrapolations suggest that figure could reach over $1.1 Billion by 2035, reflecting continued future expansion. Analyst estimates provide inputs for the first five years, while longer-term numbers are modeled by Simply Wall St using industry growth trends.

    Based on this model, the estimated intrinsic value of Amneal Pharmaceuticals is $69.18 per share. In comparison to its current share price, this result indicates the stock trades at a significant 81.9% discount relative to its calculated fair value, which suggests potential undervaluation.

    Result: UNDERVALUED

    Our Discounted Cash Flow (DCF) analysis suggests Amneal Pharmaceuticals is undervalued by 81.9%. Track this in your watchlist or portfolio, or discover 914 more undervalued stocks based on cash flows.

    AMRX Discounted Cash Flow as at Nov 2025

    Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Amneal Pharmaceuticals.

    The price-to-sales (P/S) ratio is often the preferred valuation metric for companies like Amneal Pharmaceuticals, especially when profits are relatively low or volatile but revenue trends remain steady. For profitable companies, the P/S ratio offers a clear sense of what investors are willing to pay for each dollar of sales. This makes it a practical tool for comparing valuations, particularly in fast-evolving sectors such as pharmaceuticals.

    It is important to remember that growth expectations and company-specific risks play a large role in determining what constitutes a “normal” or fair P/S ratio. Companies with higher growth rates or lower risks typically warrant a higher ratio, while those facing headwinds tend to trade at a lower ratio.

    Currently, Amneal trades at a P/S ratio of 1.34x. This compares to the pharmaceutical industry average of 4.18x and the peer average of 17.11x, suggesting the market is placing a lower value on each dollar of Amneal’s sales relative to its competitors.

    However, Simply Wall St’s proprietary Fair Ratio goes further by factoring in unique aspects of Amneal’s business, such as its projected earnings growth, profit margin profile, market capitalization, and any business-specific risks. Unlike a simple peer or industry comparison, the Fair Ratio is a comprehensive benchmark designed to reflect what the multiple truly should be. Amneal’s Fair Ratio is 2.90x.

    Comparing Amneal’s current multiple to the Fair Ratio indicates the stock is meaningfully undervalued by this measure, with a significant gap between its P/S of 1.34x and its Fair Ratio of 2.90x.

    Result: UNDERVALUED

    NasdaqGS:AMRX PS Ratio as at Nov 2025
    NasdaqGS:AMRX PS Ratio as at Nov 2025

    PS ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1437 companies where insiders are betting big on explosive growth.

    Earlier we mentioned that there is an even better way to understand valuation, so let’s introduce you to Narratives. A Narrative is your personalized story behind a stock. It connects your expectations for the company’s future (such as revenue growth, earnings, and margins) with a financial forecast and a resulting fair value, all in one place.

    Rather than just relying on static metrics, Narratives add context to the numbers by letting you articulate the key drivers and risks you believe matter most. On Simply Wall St’s Community page, millions of investors use Narratives to build, compare, and follow these dynamic investment outlooks, making them both accessible and actionable.

    Narratives make it easy to monitor your investment rationale: they continuously show how your fair value compares to the current price, and automatically update whenever news or financial results change the outlook.

    For example, some investors see Amneal Pharmaceuticals’ global expansion and robust pipeline as reasons to assign a higher fair value, while others point to industry risks and high debt as justification for more conservative estimates. Narratives help you weigh both perspectives, ensuring that your investment decision is shaped by your own view, not just the latest headline.

    Do you think there’s more to the story for Amneal Pharmaceuticals? Head over to our Community to see what others are saying!

    NasdaqGS:AMRX Community Fair Values as at Nov 2025
    NasdaqGS:AMRX Community Fair Values as at Nov 2025

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

    Companies discussed in this article include AMRX.

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

    Continue Reading